The estimated Net Worth of John Nicholson is at least $23.8 Million dollars as of 16 August 2019. John Nicholson owns over 3,819 units of Nektar Therapeutics stock worth over $203,449 and over the last 17 years John sold NKTR stock worth over $23,627,049.
John has made over 26 trades of the Nektar Therapeutics stock since 2015, according to the Form 4 filled with the SEC. Most recently John sold 3,819 units of NKTR stock worth $69,315 on 16 August 2019.
The largest trade John's ever made was exercising 385,000 units of Nektar Therapeutics stock on 11 August 2015 worth over $3,022,250. On average, John trades about 25,154 units every 29 days since 2007. As of 16 August 2019 John still owns at least 162,759 units of Nektar Therapeutics stock.
You can see the complete history of John Nicholson stock trades at the bottom of the page.
John's mailing address filed with the SEC is C/O NEKTAR THERAPEUTICS, 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158.
Over the last 21 years, insiders at Nektar Therapeutics have traded over $57,608,493 worth of Nektar Therapeutics stock and bought 90,000 units worth $1,628,550 . The most active insiders traders include Howard W Robin, Gil M Labrucherie, and John Nicholson. On average, Nektar Therapeutics executives and independent directors trade stock every 11 days with the average trade being worth of $36,648. The most recent stock trade was executed by Jonathan Zalevsky on 19 August 2024, trading 6,866 units of NKTR stock currently worth $8,788.
nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.
Nektar Therapeutics executives and other stock owners filed with the SEC include: